CYTOMX

Welcome to the Brand page for “CYTOMX”, which is offered here for Biological drugs for use in treating cancer, and autoimmunity; therapeutic and medical diagnostic agents and preparations for use in therapies and diagnosis for cancer, and autoimmunity; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies and medical diagnosis for cancer, and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immune system, cells, or genes; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic and diagnostic agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic and medical diagnostic agents, preparations and substances in the field of cancer, and autoimmunity for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “CYTOMX” is believed to be currently owned by “CytomX Therapeutics, Inc.”